• Home
  • Search Results

Search Results

397 studies match your search
Open

Training Brain-Muscle Communication

Are you curious about how your brain and muscles communicate during everyday tasks? We're looking for healthy adults (18-30 years old) to take part in a research study exploring how biofeedback can improve muscle control. You'll complete simple hand grip exercises while we measure brain and muscle activity using advanced techniques and tools. No prior experience required. Compensation up to $105 is provided for your time. Help us discover new ways to improve movement in people with neurological conditions, like stroke recovery!

Age & Gender
  • 18 years ~ 30 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Brain, Head, Nervous System
  • UNC Students (undergrad, grad, professional)
  • and 2 more
Open

Registry of patients with EoE treated with Dupixent

This study is researching the treatment outcomes and long-term effects of a drug called Dupixent in treatment of patients with Eosinophilic Esophagitis (EoE).

Age & Gender
  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Stomach, Digestion and Gut Health
  • Ear, Nose, and Throat
Visit Location
100% Remote (online, phone, text)
Open

MB-105 in Patients with CD5 Positive Relapsed/Refractory T-Cell Lymphoma

Do you have T-cell Lymphoma? Is your disease relapsed or refractory and CD5 positive? If so, you may be able to participate in this gene therapy research study to learn more about using your own modified immune cells as possible treatment.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

C-section Infection Prevention Study

Are you pregnant? Are you planning a scheduled cesarean delivery? If so, you may be able to take part in a study to see if using two antibiotics before a C-section instead of just one can lower the risk of infections. The infections we want to prevent are womb infection, wound infection, or a serious blood infection. Compensation provided.

Age & Gender
  • 14 years ~ 99 years
  • Female
Study Interest
  • Pregnancy
Visit Location
100% Remote (online, phone, text)
Open

Petosemtamab Drug Study

Do you have incurable, metastatic/recurrent head and neck squamous cell carcinoma? If so, you may be able to take part in a study to see if a new drug called petosemtamab is effective. We want to see if petosemtamab works better than the treatments doctors usually use for head and neck squamous cell carcinoma. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Open

Study of RP1 in Organ and Cell Transplant Patients With Skin Cancer

Have you had an organ transplant or hematopoietic cell transplant and have advanced cutaneous squamous cell carcinoma? If so, you might be eligible to take part in a study to see if an investigation drug, RP1, can help treat your skin cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Other Cancers)
Open

The ARC Study

Help us advance research for cerebellum disorders! The ARC Study (Advancing Research for Cerebellum Disorders using 3T & 7T MRI) is currently looking for healthy participants to participate in a research study involving brain MRI scans. Participants can earn up to $100 in giftcards for participation.

Age & Gender
  • 14 years ~ 21 years
  • Female
Study Interest
  • Brain, Head, Nervous System
  • Developmental
  • Healthy Volunteer or General Population
  • UNC Students (undergrad, grad, professional)
Open

Pediatric Ravulizumab Study

This is a research study for pediatric patients previously been diagnosed with generalized myasthenia gravis (gMG) which is a condition that causes abnormalities of your immune system which may lead to generalized muscle weakness. This study looks at an investigational drug called ravulizumab (referred to as "study drug") to treat gMG by blocking complement activity that fights against infections. Although ravulizumab is approved to treat gMG in adults, in this study, ravulizumab is considered an experimental drug, which means it is not approved for use in treating children with gMG in any country at this time.

Age & Gender
  • 6 years ~ 17 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Chronic Conditions
Open

Study for Patients with Non-small Cell Lung Cancer

Have you been diagnosed with Stage III non-small cell lung cancer? Is your cancer advanced and not able to to removed? If so, you might be able to participate in a study that looks at a study drug to see if it can help the radiation treatment work better against your cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung)
Open

PRevention Of Frailty with Fisetin (PROFFi) in Breast Cancer Survivors

Are you a breast cancer survivor? if soy you may be eligible to participate in this research study that is looking at the effectiveness of fisetin and/or exercise on physical function assessed using a 6 minute walking distance in chemotherapy-treated postmenopausal breast cancer survivors

Age & Gender
  • 18 years ~ 70 years
  • Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research